The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.
This month, Columbus CyberKnife honors five years of cancer care since opening on the campus of hospital partner Mount Carmel St. Ann’s Hospital.
In a recent study, researchers demonstrated the efficacy of stereotactic radiosurgery (SRS) in the treatment of brain metastases, or tumors that have spread from a primary tumor in another area of the body to the brain.
June 15 - 21 is honored as Men’s Health Week, dedicated to raising awareness for all aspects of men’s health.
In a recent study examining the efficacy of CyberKnife for the treatment of lung cancer metastases, researchers determined that patients may experience better local control and low toxicity.
A recent prostate cancer study examined the outcomes of CyberKnife treatment for low and immediate risk patients with early stage prostate cancer.
For some patients, maintaining a daily routine is important, particularly for those who work or travel. Fortunately, as cancer technology and approaches to treatment have advanced, there are options and methods available that can help to reduce the impact of cancer treatment on a patient’s daily routine.
CyberKnife offers an effective and convenient cancer treatment option. Watch the video in this post to hear about the experience of Ward, a former CyberKnife prostate cancer patient.
Acoustic Neuroma Awareness Week 2015 is celebrated nationwide May 10 – 16.
Two studies presented at the 2014 annual meeting of the European Association of Neurosurgical Societies (EANS) reinforce the benefits of stereotactic radiosurgery for neurological diseases using the CyberKnife® system.